Evidence map›Paper›PMID 39568491›Full record

ArticleCureus2024

Effectiveness of Flow Diverter Stents in the Treatment of Intracranial Aneurysms: Single-Center 10-Year Results.

Cemre Ozenbas, Suleyman Men, Ozkan Alatas, Mehmet Akif Kamar

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cemre OzenbasRadiology, Tınaztepe University Buca Hospital, Izmir, TUR.
Suleyman MenRadiology, Dokuz Eylul University Research and Application Hospital, Izmir, TUR.
Ozkan AlatasRadiology, Izmir State Hospital, Izmir, TUR.
Mehmet Akif KamarRadiology, Kırsehir State Hospital, Kırsehir, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose This study's objective was to show how effectively flow-diverting stents work when treating cerebral aneurysms. The assessment aimed to determine efficaciousness related to aneurysm type, size, and location as well as early- and late-term results. Material and method The study included 153 aneurysms from 122 patients treated in interventional radiology unit with flow diverter stents between July 2010 and June 2020. Apart from demographic data, size, type, and location of aneurysms; technical success, peri, post-procedural, and late complications; aneurysm occlusion rates, morbidity and mortality rates were extracted from patient records. Results This study enrolled 90 (73.8%) females and 32 (26.2%) males; average age of the patients was 52.8±12.9. The average follow-up period was 33.4±9.9 months. The most common type of aneurysm was saccular (133; 86.9%), and the most common location was the supraclinoid segment with 67 (43.8%). Complete occlusion was observed in 115 of 140 aneurysms from 110 patients during follow-up. No statistically significant difference was detected between the sizes and types of aneurysms and complete occlusion rates (p=0.096, p=0.583). The total occlusion rate was found to be significantly higher in internal carotid artery (ICA) supraclinoid segment aneurysms compared to other locations (p = 0.006). During the follow-up period, flow diverter stent-related permanent morbidity was observed in four (3.6%) patients and mortality was observed in five (4.5%) patients. Conclusion Flow diverter stents can be successfully applied to many aneurysm types, from small aneurysms to large and giant aneurysms, and have high aneurysm occlusion rates with low morbidity and mortality. By the aspects of the current study the total occlusion rate was found to be significantly higher in ICA supraclinoid segment aneurysms compared to other localizations.

Indexed as

endovascular treatmentflow diverter stentinterventional radiologyintracranial aneurysmradiology

Identifiers

PMID39568491
PMCPMC11577147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.